{"id":8876,"date":"2020-09-24T12:12:29","date_gmt":"2020-09-24T16:12:29","guid":{"rendered":"https:\/\/www.simonssearchlight.org\/?page_id=8876"},"modified":"2025-02-18T08:21:02","modified_gmt":"2025-02-18T13:21:02","slug":"community-advisory-committee","status":"publish","type":"page","link":"https:\/\/www.simonssearchlight.org\/about\/community-advisory-committee\/","title":{"rendered":"Community Advisory Committee"},"content":{"rendered":"

Simons Searchlight<\/span> is a partnership of leading scientists, doctors, patient advocacy leaders, clinicians, participants, and families, determined to accelerate science and improve lives for people with rare genetic neurodevelopmental disorders. As part of this mission, Simons Searchlight<\/span> works with a Community Advisory Committee<\/span> (CAC) whose purpose is to advise and guide research and community activities on behalf of all Simons Searchlight<\/span> participants and genetic communities.<\/h4>\n

Read more about the current members below.<\/h4>\n

 <\/p>\n

\n

\"\"<\/b><\/p>\n

Christie Abercrombie<\/strong><\/p>\n

Christie Abercrombie is a dedicated individual with a passion for making a difference in the lives <\/span>of others. With a degree in psychology and 10 years of pharmaceutical sales, she brings a <\/span>strong scientific background to her philanthropic pursuits. Christie has spent many years <\/span>actively engaged in charity service, demonstrating a deep commitment to helping her state <\/span>change archaic laws.<\/span><\/p>\n

In addition to her academic achievements, Christie has gained valuable experience working with <\/span>children with many different abilities. As the current children\u2019s director at her church, Christie is <\/span>committed to providing compassionate care and support to all children, including those facing <\/span>unique challenges.<\/span><\/p>\n

With a heart full of compassion and a mind grounded in scientific knowledge, Christie continues <\/span>to make a meaningful impact in both the scientific community and the realm of charitable <\/span>service, embodying the spirit of service in her life\u2019s work.<\/span><\/p>\n

\"\"<\/b><\/p>\n

Luca Rino Belloni<\/strong><\/p>\n

Luca Belloni is a Strategic Advisor for a group of companies. He is Italian and lives in Italy with his wife, Francesca, and their three children: Tommaso (10), Giorgio (7), and Alessia (6 months). Giorgio has a mutation in the PPP2R5D gene, diagnosed at age 2 through whole exome sequencing. Since then, Luca has been deeply involved with Jordan\u2019s Guardian Angels, working tirelessly to advance research on the disease. In 2025, with crucial support from Simons Searchlight<\/span>, this research will lead to clinical trials for a potential treatment.<\/p>\n

Luca is also dedicated to supporting families affected by the disease, both internationally and locally. In Italy, he is establishing a national branch of Jordan\u2019s Guardian Angels to raise awareness, support families, fund research, and advocate for European approval of FDA-authorized treatments. To achieve this, Luca is collaborating with Italian institutions and encouraging the creation of similar efforts across Europe, aiming for stronger representation in European regulatory bodies.<\/p>\n

On a global level, Luca actively engages with the international community of families, both virtually and in person. He is proud and honored to contribute to Simons Searchlight<\/span>\u2019s initiatives locally, across Europe, and worldwide.<\/p>\n

\"\"<\/b><\/p>\n

April Canter<\/strong><\/p>\n

April Canter is a federal strategy director for the American Association for Retired Persons (AARP), April engages in advocating for the interests of the 50+ community while collaborating closely with Congressional Republicans. Her role involves strategizing and promoting initiatives aimed at benefitting this demographic.<\/p>\n

Before assuming her current position, she served as the coalition’s director & senior legislative assistant for Congressman Joe Sempolinski (NY-23). In this role, she managed various aspects of the Congressman’s legislative endeavors, including Congressional appropriations requests, co-sponsorship movement, and stakeholder engagement.<\/p>\n

Prior to her work with Congressman Sempolinski, she spent four years at the Harley-Davidson Motor Company. Her responsibilities included overseeing the US government affairs strategy and managing the Harley Political Action Committee (HarleyPAC).<\/p>\n

April’s professional background also encompasses advocating for the scope of practice of advanced practice registered nurses for the American Nurses Association and safeguarding artists’ intellectual property rights for the Recording Academy \u2013 The Grammys.<\/p>\n

With a deep-rooted passion for public service, April has held roles at all levels of government \u2013 municipal, county, state, and federal \u2013 across the legislative, executive, and judiciary branches.<\/p>\n

Originally from Arizona, she pursued a BS in political science from Northern Arizona University and obtained a master’s degree in public administration from the University of Colorado at Denver.<\/p>\n

\"\"<\/b>Jacquelyn Cattage<\/strong><\/p>\n

Jacquelyn Cattage was born and raised in Jackson, MS.\u00a0 She obtained an undergraduate degree in psychology from the <\/span>University of Mississip<\/span>pi (Ole Miss) and moved to Saint Louis, MO where she trained and received a doctorate in clinical psychology at Saint Louis University. She c<\/span>ompleted her postdoctoral training at Family Care Health Centers and has remained on staff at the federally qualified health center to this day with a clinical focus in pediatric behavioral health issues and assessment of Autism in children and adolescents. <\/span><\/p>\n

She is also involved in medical education, holding the position of part-time adjunct behavioral science faculty in the SSM Saint Louis University Family Medicine Residency in St. Louis. Jacquelyn is a wife and mother of three young children, one of whom was diagnosed with a rare genetic condition (SETD5 deletion) in 2020. Jacquelyn is passionate (both personally and professionally) about helping families gain education and understanding of neurodevelopmental conditions and reducing barriers to accessing assessment, treatment, and support services, especially within the BIPOC (black, indigenous, and people of color) community. She is excited to have been chosen to participate on the Simons Searchlight<\/span> Community Advisory Committee<\/span> to help and support creative efforts to expand outreach to those communities that are currently underrepresented in the medical research of rare genetic conditions.<\/span><\/p>\n

\"\"Sarah Davis<\/strong><\/p>\n

Sarah Davis, PhD is a sterility assurance drug reviewer for the Food and Drug Administration (FDA). She holds a PhD in microbiology from the University of Tennessee and a bachelor\u2019s in microbiology from Clemson University. Prior to her work as a reviewer, she conducted microbial pathogenesis research for the National Institutes of Health (NIH) and later at the University of Maryland. Research at each institution has resulted in peer-reviewed scientific publications in the fields of both bacterial and fungal pathogenesis.<\/p>\n

While attending graduate school she met her husband Steve, a microbiology postdoctoral fellow, and together they raise their young daughter Holly. At 23 months, Holly was diagnosed with autism and speech delay. Following the autism diagnosis whole exome sequencing was performed, which revealed that both Sarah and Holly carry a pathogenic variant\/ mutation in the RERE gene. RERE-related neurodevelopmental disorders are associated with developmental delays, autism spectrum, and low muscle stone. As a child Sarah also had a significant speech delay, which may be explained by this mutation. The genetic sequencing results have given her family a better understanding of both Sarah\u2019s and Holly\u2019s childhoods. Sarah is happy to join the Simons Searchlight<\/span> CAC. She resides with her family in Silver Spring, MD and is originally from Florence, SC.<\/p>\n

\"\"Delf<\/strong><\/p>\n

Delf is a seasoned IT professional with over 20 years of experience and a passion for global cultures. Having lived and worked in countries such as the United States, Argentina, India, and the Philippines, he brings a multicultural perspective to his leadership style. He holds an MBA in Information Technology and a Bachelor of Science in Business Computer Systems.<\/p>\n

With a background in cybersecurity, digital workplace solutions, and product management, Delf currently leads teams at a large multinational company, focusing on automation, data analytics, and user experience. He has a proven track record in delivering enterprise-scale solutions and driving innovation.<\/p>\n

Delf’s approach is defined by his core strengths: as a Relator, he excels at building meaningful connections; as a Maximizer, he brings out the best in people and projects; his Analytical mindset enables him to break down complexities, and his Achiever drive ensures he meets and surpasses goals.<\/p>\n

Married to a Brazilian, Delf is a proud husband and a hands-on dad to his nine-year-old daughter. He enjoys balancing his career with family life, fostering creativity, having fun, and exploring the world together.<\/p>\n

\"\"Alida James-Fenner<\/strong><\/p>\n

Alida James-Fenner is a former educator, teacher mentor\/coach, school\/museum administrator, educational technology consultant, constan<\/span>t maker of to-do lists and a vocal advocate for her son, Evan. He was diagnosed with 2q23.1 microdeletion syndrome in 2012 at age four. Now known as MA<\/span>ND (MBD5-Associated Neurodevelopmental Disorder), Evan is one of about 600 known cases worldwide. Although there is variation among those diagnosed with MAND, Evan\u2019s diagnosis includes Autism, Intellectual Disability, ADHD, Epilepsy, Scoliosis, Bilateral degenerative progressive high myopia, and a myriad of other medical and educational concerns. He is also kind, expressive, clever, joyful, loving, and a whiz with any sort of technology.<\/span><\/p>\n

Alida helps to moderate numerous support spaces; including the 2q\/MAND Caregiver Support group and the MAND Research Roundtable on Facebook. She is active in her local community as well, most recently working with the Mid-Atlantic Equity Consortium as a Maryland Parent Representative. She prides herself on finding opportunities for Evan to participate in as many adapted activities as possible, including waterskiing, boating, camping, theater, hip-hop and ballet classes, karate, and Miracle League to name a few.\u00a0<\/span><\/p>\n

Alida is excited to join the Community Advisory Council this year. She hopes to bring attention to MAND as a research opportunity for scientists, to highlight some of the unique challenges of being a member of a minority group while also being diagnosed with a rare disorder, and to offer continued support and knowledge to \u201c2qties\u201d and their families around the World.\u00a0<\/span><\/p>\n

She lives in Maryland with her husband Jesse and their son.<\/span><\/p>\n

\"\"<\/b>Rebeca Ridings Figueroa<\/strong><\/p>\n

Rebeca is the Research Program & Charity Manager at Cure CLCN4. Her role is to help advance the goals of Cure CLCN4, working with the Board of Trustees to develop, shape and implement Cure CLCN4\u2019s research strategy, policy and governance. Originally from the Canary Islands (Spain), Rebeca completed a PhD in Genetics at the University of Cambridge. She also holds a Master’s by Research and a BSc in Molecular Cell Biology from the University of York. <\/span><\/p>\n

Simons Searchlight<\/span> has been an integral part of Cure CLCN4\u2019s mission of moving the research on CLCN4-related conditions forward, and Rebeca is now excited to give back by bringing her energy and expertise to the Simons Searchlight<\/span> CAC and to contribute to the CAC’s mission of supporting and shaping research initiatives within the Simons Searchlight<\/span> community.<\/span><\/p>\n

\n

\"\"<\/b><\/p>\n<\/div>\n

Amy Fields <\/strong><\/p>\n

Amy Fields adopted two children with rare conditions out of foster care. Her oldest has the KME2E mutation. When he was diagnosed, there was little information available. Amy joined up with other parents in the KMT2E community and formed a group to provide education, connections, and hope.<\/p>\n

Amy is a teacher and advocate. She served on the FAC at Children’s Hospital in MN where she focused on patient centered care, bereavement, and helped rewrite educational materials to make them more family friendly. Currently Amy is working for The Lucas Project, a non-profit organization that supports parent caregivers. In her spare time Amy enjoys spending time with her family, reading about Tudor history, and enjoying long Minnesota winters.<\/p>\n<\/div>\n

\"\"Michelle Gamble<\/strong><\/p>\n

Michelle Gamble, lives in Leicestershire, England with her husband and is a proud mother to three children, aged 21,17 and 7.<\/p>\n

Their youngest child was diagnosed aged three with a rare genetic syndrome VPS13B \u2013 Cohen Syndrome. She has complex care needs, learning disabilities and Autism. Michelle was a dedicated registered adult nurse, graduating from Demontfort University in Leicester. She worked for many years on hospital wards and moved onto work as a nurse consultant, assisting community care settings with compliance. For the last eight years Michelle has been working as an early year practitioner, she runs a pre-school setting with her husband and oldest son for children aged 0-5, many of whom have a wide variety of additional needs.<\/p>\n

Michelle is excited to join Simons Searchlight<\/span>\u2019s CAC, with her professional background in healthcare, early years education and her personal experience as a parent carer, she brings a unique and compassionate perspective to the role.<\/p>\n

\"\"Adrienne M. Gilligan<\/strong><\/p>\n

Adrienne M. Gilligan, PhD is a Director of Value, Evidence and Outcomes in Oncology at Eli Lilly where she develops and oversees health economics and outcomes research (HEOR) strategy from clinical development through commercialization for the oncology pipeline. She is a senior-level HEOR professional with over 10 years of experience in the pharmaceutical industry in the areas of health economics, outcomes research, pricing and reimbursement, and health technology assessment. In addition, she has served as an adjunct assistant professor at the University of North Texas School of Pharmacy since 2013. She has experience developing and conducting various applied research and data analytic methods and has an extensive knowledge of a wide variety of methods and models analyzing health disparities, cost of care, resource utilization, quality-of-life indicators, and retirement trends working with large retrospective databases. Her research has resulted in multiple publications across a variety of therapeutic areas, including oncology, neurology, cardiology, and wound care.<\/p>\n

Dr. Gilligan holds a PhD and master\u2019s degree in pharmaceutical economics, policy and outcomes from the University of Arizona and a bachelor\u2019s in economics from the University of North Texas. She lives in Forth Worth, TX with her husband (Jason), 2-year old son (Vincent), 1-month old son (Caleb) and their vizsla (Yoshi). Her son, Vincent, was diagnosed with ARID1B-related disorder in November 2022. She hopes to be able to contribute to the CAC as an advocate for her son.<\/p>\n

\n

\"\"<\/b><\/strong><\/p>\n

Ross Kenyon\u00a0<\/strong><\/p>\n

Ross Kenyon is the adoptive parent of a son with a rare genetic disorder. With a background in climate technologies and fostering early-stage ventures, Ross has developed a unique skill set in translating complex ideas and supporting impactful initiatives. He has worked across diverse sectors, including carbon removal, regenerative agriculture, and financial innovation, always with an eye toward creating meaningful change. <\/span><\/p>\n

Joining the Simons Searchlight<\/span> Community Advisory Committee<\/span>, Ross is passionate about advancing research and building community support for individuals with genetic neurodevelopmental disorders.<\/span><\/p>\n

\"\"<\/b>Piotr Kosla\u00a0<\/strong><\/p>\n

Piotr Kosla is a proud parent of 2 years old fraternal twin girls \u2013 Lena & Zuzia. Lena has extremely ultra rare, single point mutation in the PACS2 gene with only dozens of cases diagnosed worldwide.<\/p>\n

Following Lena\u2019s rapid diagnosis thanks to whole exome sequencing (7 weeks from 1st seizure) in February 2022, together with his wife Malgorzata, they have decided to take advantage of their entrepreneurial spirits to save their daughter and founded PACS2 Research Foundation (May 2022) to start exploration around PACS2 syndrome. Completely from scratch as a mechanism of action is unknown. Today, they work with several scientists across the whole world, actively managing 7 projects and pushing science to help all patients with PACS2 syndrome, almost all of whom have a mutation in the same place.<\/p>\n

Very quickly, together with his wife Malgorzata, they went beyond PACS2 syndrome, supporting other families and helping them navigate in this complex world. \u201cI am thrilled to be joining Simons Searchlight<\/span> as a CAC member, a program with whose mission I am fully aligned, where I can leverage my professional background and personal journey to uplift and advocate for families impacted by rare diseases. The opportunity to contribute to this cause ignites an unparalleled sense of purpose within me, underscoring the importance of supporting others in their moments of greatest need. The rare diseases community has captured my profound interest, and I am committed to driving scientific progress and bringing the international voice of rare disease patients and their families.\u201d<\/p>\n

Piotr holds a master\u2019s degree in finance & international management, but quickly turned his pathway towards commercial bringing experience from various industries and today he is focusing on rare diseases in his professional life. He is rare- disease community contributor 24\/7. He lives with his family in Warsaw, Poland.<\/p>\n

\"\"<\/b>Alberta McWilliams<\/strong><\/p>\n

Alberta lives on the North Coast of Northern Ireland and works within the Northern Ireland Civil Service as a Staff Officer in the Department for Infrastructure (2001 to present). Her various roles have allowed her to gain valuable skills in presentation, communication, working collaboratively, analysis and critical thinking.<\/p>\n

Alberta is the proud mother of b\/g twins, Ada & Thom, who were born in April 2016 prematurely. Ada had a very low birth weight (3.5lbs) and a difficult journey followed through the next few years. Ada received a genetic diagnosis of CUL-3 related neurodevelopmental disorder in February 2023 which was both a shock but also a comfort in that the difficulties experienced could now be put into context.<\/p>\n

Alberta is looking forward to participating fully in CAC to help find solutions and to strive for progress. She hopes to help other families who find themselves in a similar position.<\/p>\n

\"\"<\/b>Kaitlin Miller<\/strong><\/p>\n

Kaitlin Miller, MSN, MBA, RN is Director of Clinical Quality at OneOncology where she overseas a Qualified Clinical Data Registry as well as performance in governmental and commercial value-based care programs. She is a dedicated healthcare professional with over 13 years of professional experience with a deep commitment to driving innovation in healthcare through improvement in quality of patient care and increased access. With a strong background in clinical operations and strategic planning, Kaitlin has spent years working to enhance outcomes for patients with chronic conditions and a deep passion for providing care in the community, keeping patients out of the hospital and enabling more days spent at home.<\/p>\n

Kaitlin\u2018s eldest child was diagnosed in 2024 at the age of 10 with NAA15 syndrome through the Simons foundation Spark study for autism after enrolling in 2019 when standard care had little to offer. This personal experience combined with a deep understanding of the healthcare systems and payer programs has inspired a new passion for advocacy in research and healthcare solutions for those affected by rare disease. She regularly works with local providers on the benefits and process of becoming enrolled with children\u2019s long term support services to increase access for therapeutic and recreational activities within the community for families and children effected by rare disease and disability. She is excited to be joining the Community Advisory Council as she begins her journey in understanding the rare disease space and finding where she can help make a difference.<\/p>\n

Kaitlin holds dual Master\u2019s degrees in Nursing Administration and Business Administration from Kent State University, along with a Bachelor of Science in Nursing.<\/p>\n

\"\"<\/b>Erin Morgan<\/strong><\/p>\n

Erin Morgan is a dedicated advocate for individuals impacted by rare diseases, driven by her personal experience as a mother of a daughter diagnosed with IRF2BPL-Related Disorder in 2024. Her journey began with a profound desire to make a difference, leading her and her husband to establish a nonprofit organization called Tough Genes, focused on raising awareness and funding research to improve the lives of those affected by IRF2BPL mutations.<\/p>\n

As a member of the Simons Searchlight<\/span> Community Advisory Committee<\/span>, Erin brings a current perspective of the struggles and life altering effects of a rare diagnosis. Her personal experience, combined with her dedication, drives her ongoing efforts to shine a spotlight on these challenges faced by rare disease patients and their families. She is excited to work alongside other rare disease leaders to continue to improve Simons Searchlight<\/span> and ensure that the information is both accessible and relevant to patient communities and researchers.<\/p>\n

Erin has a professional background in Human Resources. Her passion for helping others, effective communication and solving problems in the workplace brings a valuable skill set to the rare disease space. She is committed to advancing scientific knowledge and medical understanding of ultra rare genetic disorders while supporting and uplifting patients and families. Every family deserves answers, every patient deserves treatment.<\/p>\n

\"\"<\/b><\/p>\n<\/div>\n

Ashley Point<\/strong><\/p>\n

Ashley Point grew up in Marietta, Georgia and graduated from the University of Kentucky. <\/span>Ashley worked in national political fundraising for 10 years before attending medical school at <\/span>Marshall University, where she met her husband, Dana.\u00a0 After two years, she left medical school to stay home with their three children \u2013Jackson (born 2012), Davis (2014) and Alex Cate (2017). Ashley became interested in Koolen-de Vries Syndrome (KdVS) after her son, Davis, was diagnosed with Koolen-de Vries Syndrome (KdVS) at 16 months old.\u00a0 She serves as President of the KdVS Foundation and the My Kool Brother Foundation. <\/span><\/p>\n

Ashley feels that collaboration i skey to treatments and cures for neurological disorders and is excited to join the Simons Searchlight<\/span> Community Advisory Committee<\/span> (CAC). Ashley and her family currently reside in Wilmington, North Carolina.<\/span><\/p>\n

\"\"<\/b><\/strong><\/p>\n

Victoria Powell<\/strong><\/p>\n

Dr. Powell is an assistant professor at the University of Michigan in the division of Geriatric and Palliative Medicine. She is also a research investigator and staff physician at the LTC Charles S. Kettles VA Medical Center in Ann Arbor, MI.<\/p>\n

Her research interests include novel approaches to treatment for people living with chronic pain and complex psychosocial and existential distress states, such as loneliness and demoralization. She is principal or co-investigator on multiple clinical trials involving pharmacologic, behavioral, and combined interventions. She completed internship and residency in internal medicine at Johns Hopkins Hospital, followed by a clinical fellowship in hospice and palliative medicine at the NIH Clinical Center. In 2024, her son was diagnosed with 17p13.3 microduplication syndrome.<\/p>\n

\"\"<\/b>Genesis Romo-Raudry<\/strong><\/p>\n

Genesis is the mother of a beautiful boy with CNOT3. She holds a master’s degree in Special Education from the University of Illinois at Chicago. After earning her degree, she chose to put her career on hold to be with her children during their most formative years. This allows her to pick up her little one from school and take him to his therapies, providing opportunities to directly communicate with his teachers and therapists to implement strategies at home.<\/p>\n

Genesis enjoys doing art and crafts with her children and has a passion for creating bucket lists. She advocates for mothers seeking answers outside the box, understanding the loneliness that can accompany this journey. She believes that by sticking together, families can find answers and knowledge collaboratively.<\/p>\n

\"\"<\/b><\/p>\n

Victoria Schaible <\/strong><\/p>\n

Victoria Schaible is a Board-Certified Behavior Analyst (BCBA) residing in Virginia. Victoria obtained her undergraduate degree from Longwood University with a major in psychology in 2014, and her master’s degree in special education with a concentration in Applied Behavior Analysis (ABA) from George Mason University in 2019. Victoria has worked with children on the autism spectrum for 8 years and has been a Board-Certified Behavior Analyst for 4 years.<\/p>\n

Victoria was introduced to the world of rare genetic disorders in the fall of 2023 when her son was diagnosed with Wiedemann-Steiner Syndrome. This genetic condition affects the KMT2A gene. Since her son\u2019s diagnosis, Victoria has sought to immerse herself into learning more about rare genetic conditions and using her background and knowledge to provide education regarding Wiedemann-Steiner Syndrome, along with rare genetic disorders to others.<\/p>\n

\"\"<\/b>Liz Spitzer<\/strong><\/p>\n

Liz Spitzer, PhD is a licensed clinical psychologist and mother to her son, who has a rare genetic disease. As a psychologist, she has worked in both private practice and hospital settings, including being a clinical research psychologist studying the implementation of best practices for suicide prevention within the Department of Veterans Affairs. Liz is also the Chief Operations Officer and Co-Founder of the DYNC1H1 Association. <\/span><\/p>\n

She is excited to join Simons Searchlight<\/span>\u2019s CAC to help continue to improve Simons Searchlight<\/span> and make sure information is accessible and relevant to patient communities.\u00a0<\/span><\/p>\n

\"\"<\/b>Braxton Webb<\/strong><\/p>\n

Braxton is a 40-year-old man born and raised in Milwaukee, WI. With over 10 years of experience in the pediatric mental health field, he has dedicated his career to working with children diagnosed with autism and other behavioral and mental health issues. He has also had the privilege of working with many children diagnosed with rare genetic disorders.<\/p>\n

A US Marine Corps veteran and former sheriff deputy, Braxton is deeply committed to serving others. He is also a proud father of two children with special needs, an experience that has shaped his perspective and work. Outside of his professional life, Braxton enjoys traveling and has a passion for playing video games, with a collection of over 300 titles. Additionally, he is highly skilled at fixing electronics and computers, often using his technical expertise to help others.<\/p>\n","protected":false},"excerpt":{"rendered":"

Simons Searchlight is a partnership of leading scientists, doctors, patient advocacy leaders, clinicians, participants, and families, determined to accelerate science and improve lives for people with rare genetic neurodevelopmental disorders. As part of this mission, Simons Searchlight works with a Community Advisory Committee (CAC) whose purpose is to advise and guide research and community activities […]<\/p>\n","protected":false},"author":6,"featured_media":0,"parent":8,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"acf":[],"_links":{"self":[{"href":"https:\/\/www.simonssearchlight.org\/wp-json\/wp\/v2\/pages\/8876"}],"collection":[{"href":"https:\/\/www.simonssearchlight.org\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.simonssearchlight.org\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.simonssearchlight.org\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.simonssearchlight.org\/wp-json\/wp\/v2\/comments?post=8876"}],"version-history":[{"count":98,"href":"https:\/\/www.simonssearchlight.org\/wp-json\/wp\/v2\/pages\/8876\/revisions"}],"predecessor-version":[{"id":59721,"href":"https:\/\/www.simonssearchlight.org\/wp-json\/wp\/v2\/pages\/8876\/revisions\/59721"}],"up":[{"embeddable":true,"href":"https:\/\/www.simonssearchlight.org\/wp-json\/wp\/v2\/pages\/8"}],"wp:attachment":[{"href":"https:\/\/www.simonssearchlight.org\/wp-json\/wp\/v2\/media?parent=8876"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}